StockMarketWire.com - IXICO, the brain health company, has appointed Giulio Cerroni as chief executive with effect from 6 February.

He will take over from co-founder and current CEO Derek Hill, who will remain on the board and continue to serve the company as an executive director. Hill will have specific responsibility for deepening the company's relationships with major pharmaceutical companies, key opinion leaders and government agencies as well as advancing IXICO's pioneering range of digital technologies.

Cerroni has almost 30 years of international management experience gained in life sciences and diagnostics sectors. He was previously Managing Director of the Genomics division of LGC Group (LGC), the international life sciences measurement and testing company.

Non-executive chairman Charles Spicer said: "We are delighted to welcome Giulio to IXICO where he will work with the executive team to lead the business into its next phase of growth. Giulio brings extensive experience in both scaling operations to build businesses and supplying sophisticated products and services to the pharmaceutical and research communities.

"On behalf of the Board, I would like to acknowledge Derek's many contributions and his vision that has enabled IXICO to establish itself as a leading company focused on applying innovative digital technologies to brain health. We look forward to continuing to build the business together."


At 8:02am: [LON:IXI] IXICO plc share price was +1p at 37.5p



Story provided by StockMarketWire.com